| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/10/2002 | WO2001042423A3 Compositions and methods for detecting stress-inducible proteins |
| 05/10/2002 | WO2001036638A3 Polypeptides and nucleic acids encoding same |
| 05/10/2002 | WO2001036486A3 Scfv antibodies against disease associated molecules |
| 05/10/2002 | WO2001036432A3 18 human secreted proteins |
| 05/10/2002 | WO2001031007A9 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 05/10/2002 | WO2001030972A3 Regulation of gene expression by neuroleptic agents |
| 05/10/2002 | WO2001027146A9 Chemokine receptor |
| 05/10/2002 | WO2000073349A9 Dr4 antibodies and uses thereof |
| 05/10/2002 | WO2000058339A3 50 human secreted proteins |
| 05/10/2002 | CA2427952A1 Dna expression vectors |
| 05/10/2002 | CA2427850A1 Interferons, uses and compositions related thereto |
| 05/10/2002 | CA2427802A1 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof |
| 05/10/2002 | CA2427800A1 Prokineticin polypeptides, related compositions and methods |
| 05/10/2002 | CA2427539A1 Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/10/2002 | CA2395324A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | WO2002036153A1 Expression potentiator for protein synthesis regulatory gene |
| 05/09/2002 | US20020056151 Polypeptide for use as an insecticide; for generation of disease resistant plants |
| 05/09/2002 | US20020055614 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated |
| 05/09/2002 | US20020055492 Recognizes the extracellular domain of the human IFN-R and which has neutralizing capacity against the biological properties of human type I-IFN. |
| 05/09/2002 | US20020055480 SOX-9 gene and protein and use in the regeneration of bone or cartilage |
| 05/09/2002 | US20020055476 RAMPs are small proteins that transport calcitonin-receptor-like proteins to the plasma membrane; drug screening |
| 05/09/2002 | US20020055467 Truncated neublastin, of the glial cell-derived nerve growth factor (GDNF) subfamily; when dimerized, binds to a RET (a receptor tyrosine kinase) polypeptide |
| 05/09/2002 | US20020055183 Proteins involved in cytoadhesion of plasmodlum falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection |
| 05/09/2002 | US20020055158 Human tissue inhibitor of metalloproteinase-4 |
| 05/09/2002 | US20020055146 Control of the expression of anchored genes using micron scale heaters |
| 05/09/2002 | US20020055145 Isolating preferential polypeptide; obtain sample, incubate with ion exchange resin, elute, recover polypeptide |
| 05/09/2002 | US20020055142 Major intrinsic protein (MIP)-like polynucleotides, polypeptides, and antibodies |
| 05/09/2002 | US20020055140 Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis |
| 05/09/2002 | US20020055138 Staphylococcal GTPase obg nucleotide sequence encoding Staphylococcal GTP-binding protein |
| 05/09/2002 | US20020055137 Methods for detecting nucleic acid molecules encoding flh2882, a GPCR showing homology to the 5HT family of receptors |
| 05/09/2002 | US20020055136 Soluble recombinant alpha beta adhesion receptor |
| 05/09/2002 | US20020055128 Measuring binding of a candidate compound to the polypeptide (or to the cells or membranes bearing the polypeptide) or a fusion protein by means of a label associated with candidate compound, measuring binding, testing signal generated |
| 05/09/2002 | US20020055105 Method to identify interface residue in biomolecular complex |
| 05/09/2002 | US20020055097 Comparing the levels of transcription of RNA transcripts from cells of known normal tissue and suspected mutant or cancer cells |
| 05/09/2002 | US20020054879 Reacting protein with polysaccharide to produce mixture including protein-polysaccharide conjugate and free protein |
| 05/09/2002 | US20020054878 Anti-IgE antibodies |
| 05/09/2002 | US20020054876 Treatment of Alzheimer's disease |
| 05/09/2002 | US20020054870 A peptide containing atleast 6 amino acid residues, having 70% homology with part or all of the sequence containing specific 14 amino acids |
| 05/08/2002 | EP1203816A1 Amyloid beta protein agglutination controlling factor |
| 05/08/2002 | EP1203775A2 Lymphocyte chemoattractant factor and uses thereof |
| 05/08/2002 | EP1203081A2 Human intracellular signaling molecules |
| 05/08/2002 | EP1203076A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
| 05/08/2002 | EP1203025A2 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND $g(b)1 INTEGRINS |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 05/08/2002 | EP1203020A1 Modulation of human sodium channels in dorsal root ganglia |
| 05/08/2002 | EP1203018A1 26 human prostate and prostate cancer associated proteins |
| 05/08/2002 | EP1203017A1 Fab-EPITOPE COMPLEX FROM THE HIV-1 CROSS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5 |
| 05/08/2002 | EP1203015A2 Human chaperone proteins |
| 05/08/2002 | EP1203013A1 Kinase blocking polypeptides and uses thereof |
| 05/08/2002 | EP1203012A2 Refolding of membrane proteins using two different detergents |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1101113A4 Cell-signaling assays |
| 05/08/2002 | EP1092021A4 Npy-y7 receptor gene |
| 05/08/2002 | EP0721505B1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/08/2002 | EP0629240B1 Altered antibodies, products and processes relating thereto |
| 05/08/2002 | EP0627932B1 Antibody construct |
| 05/08/2002 | CN1348496A Viral vaccine |
| 05/08/2002 | CN1348492A Pseudomycin production by i(pseudomonas syringae) |
| 05/08/2002 | CN1348463A Immunological herpes simplex virus antigens and methods for use thereof |
| 05/08/2002 | CN1348011A In vitro human B lymphocyte immunizing process to produce human monoclonal antibody |
| 05/08/2002 | CN1348010A Prepn of metallothionein |
| 05/07/2002 | USH2023 Streptococcus pneumoniae sequence GrpE |
| 05/07/2002 | US6384300 Invertase inhibitor |
| 05/07/2002 | US6384299 Plant retinoblastoma-associated gene |
| 05/07/2002 | US6384203 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 05/07/2002 | US6384198 Methods for inhibiting the production of HIV-1 retrovirus using monoclonal antibodies and Fv specific for CD2 antigen |
| 05/07/2002 | US6384191 Receptors for fibroblast growth factors |
| 05/07/2002 | US6384188 Lipopolysaccharide-binding and neutralizing peptides |
| 05/07/2002 | US6384186 Cyclic dodecapeptide and process for the preparation thereof |
| 05/07/2002 | US6383793 Human osteoclast-derived cathepsin |
| 05/07/2002 | US6383785 Self-enhancing, pharmacologically controllable expression systems |
| 05/07/2002 | US6383781 Methods for producing polypeptides in aspergillus mutant cells |
| 05/07/2002 | US6383778 Nucleotide sequence which codes for receptor that binds to phenylthiocarbamide ligand; for taste modulating compounds for use in food and drug industries |
| 05/07/2002 | US6383766 Reduced cortisol conjugates |
| 05/07/2002 | US6383765 Polypeptides of feline T-cell lymphotropic lentivirus |
| 05/07/2002 | US6383760 Contacting receptor with test compound, then determining if compound binds to receptor |
| 05/07/2002 | US6383739 Drug screening by isolating blood cells then cd8+ cells from donors, culturing with compound for 3 days, culturing in with interleukin-2, detecting immunodeficiency-virus suppressing lymphokine expression, then further analysis |
| 05/07/2002 | US6383738 Herpes simplex virus ORF P is a repressor of viral protein synthesis |
| 05/07/2002 | US6383487 Antitumor |
| 05/07/2002 | US6383484 Antibodies to truncated VEGF-D and thereof |
| 05/07/2002 | CA1341357C Platelet-specific chimeric immunoglobulin |
| 05/02/2002 | WO2002034945A2 Estrogen receptor alpha variants and methods of detection thereof |
| 05/02/2002 | WO2002034933A2 Methods and compositions for modifying biologically active target molecules |
| 05/02/2002 | WO2002034921A2 FERMENTATIVE PRODUCTION OF D-p-HYDROXYPHENYLGLYCINE AND D-PHENYLGLYCINE |
| 05/02/2002 | WO2002034919A1 Variants of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 05/02/2002 | WO2002034914A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034913A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 05/02/2002 | WO2002034911A1 Mfq-114, a human ajuba like protein |
| 05/02/2002 | WO2002034909A2 Engineered chimera of hiv protein fragments and uses thereof |
| 05/02/2002 | WO2002034904A1 Novel g protein-coupled receptor protein and dna thereof |
| 05/02/2002 | WO2002034789A1 Monoclonal antibodies directed against hepatitis b viruses |
| 05/02/2002 | WO2002034788A1 Monoclonal antibodies to the map protein and method of use in treating or preventing infections |
| 05/02/2002 | WO2002034783A2 Transmembrane proteins |
| 05/02/2002 | WO2002034779A1 Identification and modification of immunodominant epitopes in polypeptides |
| 05/02/2002 | WO2002034253A1 Hair growth stimulant |
| 05/02/2002 | WO2002034119A2 Vaccine immunotherapy for immune suppressed patients |
| 05/02/2002 | WO2002034041A1 Senescence marker protein 30-defective nonhuman animal, antibody and method of constructing the same |
| 05/02/2002 | WO2002012537A3 Mutant trichosanthin |
| 05/02/2002 | WO2002008253A3 A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY |